Fourthly, GRHL2 expression suppresses stemness properties in CD44high/CD24low mesenchymal subpopulation cells of breast cancer cells and restores the anoikis sensitivity by altering intracellular H2O2 ROS levels (Cieply et al., 2012; Farris et al., 2016). The gene discussed is GRHL2; the disease is breast cancer.